Lung cancer is the number one cause of cancer death worldwide. The benefits of lung
cancer screening to reduce mortality and detect early‐stage disease are no longer in any …

Background: There are well-documented disparities in lung cancer outcomes across
populations. Lung cancer screening (LCS) has the potential to reduce lung cancer mortality …

Rural populations have higher rates of smoking and both lung cancer incidence and
mortality compared with their urban peers. As such, it is imperative that high-risk, rural …

Since, cancer is curable when diagnosed at an early stage, lung cancer screening plays an
important role in preventive care. Although both low dose computed tomography (LDCT) …

Background The Centers for Disease Control and Prevention, the American Cancer Society,
the National Cancer Institute, and the North American Association of Central Cancer …

Background Lung cancer is the no. 1 cause of cancer death in the United States.
Racial/ethnic minority and medically underserved populations suffer higher mortality than …

Simple Summary Despite an overall reduction in lung cancer incidence and mortality rates
worldwide, African Americans remain disproportionately affected by lung cancer in terms of …

International lung cancer screening (LCS) trials, using low-dose computed tomography,
have demonstrated clinical effectiveness in reducing mortality from lung cancer. This …

Introduction: Rural areas are disproportionally affected by lung cancer late-stage incidence
and mortality. Lung cancer screening (LCS) is recommended to find lung cancer early and …

Objective Given the higher rates of tobacco use along with increased mortality specific to
lung cancer in rural settings, low-dose CT (LDCT)-based lung cancer screening could be …